VEGFC negatively regulates the growth and aggressiveness of medulloblastoma cells.
Manon Penco-CampilloYannick ComoglioÁlvaro Javier Feliz MorelRita HannaJérôme DurivaultMagalie LeloireBastien MejiasMarina PagnuzziAmandine MorotFanny Burel-VandenbosMatthew SelbyDaniel WilliamsonSteven C CliffordAudrey ClarenJérôme DoyenVincent PiccoSonia MartialGilles PagèsPublished in: Communications biology (2020)
Medulloblastoma (MB), the most common brain pediatric tumor, is a pathology composed of four molecular subgroups. Despite a multimodal treatment, 30% of the patients eventually relapse, with the fatal appearance of metastases within 5 years. The major actors of metastatic dissemination are the lymphatic vessel growth factor, VEGFC, and its receptors/co-receptors. Here, we show that VEGFC is inversely correlated to cell aggressiveness. Indeed, VEGFC decreases MB cell proliferation and migration, and their ability to form pseudo-vessel in vitro. Irradiation resistant-cells, which present high levels of VEGFC, lose the ability to migrate and to form vessel-like structures. Thus, irradiation reduces MB cell aggressiveness via a VEGFC-dependent process. Cells intrinsically or ectopically overexpressing VEGFC and irradiation-resistant cells form smaller experimental tumors in nude mice. Opposite to the common dogma, our results give strong arguments in favor of VEGFC as a negative regulator of MB growth.
Keyphrases
- induced apoptosis
- cell cycle arrest
- growth factor
- single cell
- endoplasmic reticulum stress
- end stage renal disease
- cell therapy
- chronic kidney disease
- squamous cell carcinoma
- signaling pathway
- oxidative stress
- small cell lung cancer
- cell death
- high resolution
- ejection fraction
- type diabetes
- mesenchymal stem cells
- newly diagnosed
- metabolic syndrome
- radiation induced
- radiation therapy
- mass spectrometry
- prognostic factors
- pi k akt
- single molecule
- smoking cessation
- free survival